Plain-English translation of NCT07170800 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing a new drug called JDB0131 benzenesulfonate tablets as part of a combination treatment for a serious form of tuberculosis that doesn't respond to standard first-line antibiotics. You would take this medication along with several other established TB drugs for 8 weeks. The study will compare how well this new combination works and how safe it is compared to an existing treatment approach.
Drug-resistant tuberculosis is very difficult to treat, and patients need better treatment options that work faster and are easier to tolerate. This medication may help people with this hard-to-treat form of TB recover more effectively.
You likely qualify if…
You likely don't qualify if…
You would take a combination of medications by mouth every day for 8 consecutive weeks. The exact combination would depend on which group you are randomly assigned to and whether your TB bacteria are resistant to certain antibiotics. You would need to visit the clinic regularly so doctors can check how well the treatment is working, monitor you for any side effects, and take blood samples to measure the medication levels in your body.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
China